Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Pascal Pigny

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3926-4487; OpenAlex author ID A5087832482. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. A new pancreatic adenocarcinoma-derived organoid model of acquired chemoresistance to FOLFIRINOX: First insight of the underlying mechanisms. Co-author DOI 10.1111/boc.202100003↗
  2. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Last author DOI 10.1038/onc.2010.631↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Isabelle VAN SEUNINGEN · 2 shared papers, 2011–2022 · strength 0.14
  2. Charles Poiraud · 1 shared paper, 2022 · strength 0.12
  3. Nicolas Stoup · 1 shared paper, 2022 · strength 0.12
  4. Stéphanie Truant · 1 shared paper, 2022 · strength 0.12
  5. Audrey Vincent · 1 shared paper, 2022 · strength 0.12
  6. Elsa Hadj Bachir · 1 shared paper, 2022 · strength 0.12
  7. Nicolas Jonckheere · 1 shared paper, 2022 · strength 0.12
  8. J Merlin · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.